Skip to main content

Narayana Hrudayalaya Ltd

Stage 3 · Topping · week 7

As of 9 Oct 2026, Narayana Hrudayalaya is in Stage 3 — topping, where an uptrend loses steam, in week 7 (since 25 Aug 2026). It closed at ₹1,720, 17.3% below its 52-week high and below its 200-day average, which is falling. In Health Care, 44.6% of stocks are in Stage 2.

Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. More about the company

₹1,719.5
+1.43% today
₹34,923 Cr · Large cap
Market Neutral — FadingHealth Care 44.6% in Stage 2-2.6 pts / 20dHospitals & Diagnostic Centres 32.3%-6.5 pts

Pro read

Pro

Our read

Topping — the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is NH early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
vs 52W High
-17.3%
₹1,605.3 lo₹2,080.3 hi
17.3% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 7
1w13w26w
Week 7 — distribution, avoid new longs
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
-7.1%
200 DMA: ₹1,850.7 · sloping down
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.53x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↓
MA20 rolling over · -3.8% vs MA50 -3.9%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-9.4%
3M
-15.2%
6M
+0.1%
YTD
-8.4%
1Y
-0.7%
Sector
Health Care
↓ Peaking
Stage 2%
44.6%
20d Δ
-2.6pp
1M return
-4.9%
3M return
+0.2%
Sector Stage-2 % · last 20 days
Sector has 74 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
32.3%
20d Δ
-6.5pp
1M return
-8.1%
3M return
-10.8%
Industry Stage-2 % · last 20 days
Industry has 9 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →
Stage Cycle Timeline2023-07-14 → 2026-10-09
S2 41w
S3 15w
S2 37w
2023-07-142026-10-09
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 41w → S3 15w → S4 1w → S3 1w → S4 3w → S1 1w → S2 4w → S1 1w → S2 5w → S1 1w → S4 2w → S3 1w → S2 37w → S3 11w → S2 11w → S3 2w → S4 13w → S1 2w → S2 11w → S3 7w current
Total tracked: 168 weeks across 20 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-06-10
5 appearances in last 60 days. First seen: 2024-09-12.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-09S3
Wk 7 · Vol 0.53x
2026-10-08S3
Wk 7 · Vol 0.61x
2026-10-07S3
Wk 6 · Vol 0.33x
2026-10-06S3
Wk 6 · Vol 0.60x
2026-10-05S3
Wk 6 · Vol 0.31x
2026-10-01S3
Wk 6 · Vol 0.87x
2026-09-30S3
Wk 6 · Vol 1.16x
2026-09-29S3
Wk 5 · Vol 3.48x
2026-09-28S3
Wk 5 · Vol 0.51x
2026-09-25S3
Wk 5 · Vol 0.32x
2026-09-24S3
Wk 5 · Vol 0.24x
2026-09-23S3
Wk 5 · Vol 0.37x
Sector Peers — Stage 2All →
BAFNAPH
wk 18 · 0.0% from hi
8.6
ZIMLAB
wk 22 · 0.0% from hi
8.3
KILITCH
wk 2 · -7.3% from hi
8.3
SMSPHARMA
wk 3 · -8.0% from hi
8.3
RPGLIFE
wk 16 · -12.0% from hi
7.6
Moving averages & range
50 DMA
₹1,860
200 DMA
₹1,850.7
52W High
₹2,080.3
52W Low
₹1,605.3
5D Low
₹1,695.3
Resistance levels (recent highs)
20d High
₹1,928.5
60d High
₹2,080.3
120d High
₹2,080.3
250d High
₹2,080.3
Next resistance
+12.2%
to 20d High
P/E (TTM)
48.1
Forward 27.8
Earnings Growth (YoY)
+13.6%
Revenue +82.6%
ROE
+19.8%
Profit margin +10.1%
Dividend Yield
0.24%
P/B 9.6
About this companyHealth Care· Hospitals & Diagnostic Centres

Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, ultrasonology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. Narayana Hrudayalaya Limited was incorporated in 2000 and is headquartered in Bengaluru, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-09. Past data patterns are not indicative of future results. This page is a data analytics tool only.